Selective side-chain residue flexibility is an option available on AutoDock Vina docking software. This approach is promising as it attempts to provide a more realistic ligand-protein interaction environment, without an unmanageable increase in computer processing time. However, studies validating this approach are still scarce. VEGFR-2 (vascular endothelial growth factor receptor 2), a known protein target for antiangiogenic agents, was used in this study. Four residues present in the VEGFR-2 kinase site were selected and made flexible: Lys866, Glu885, Cys917 and Asp1044. The docking scores for all possible combinations of flexible residues were compared to the docking scores using a rigid conformation. The best overall docking scores were obtained using the Glu883 flexible conformation, with pearson and spearman rank correlation values of 0.568 and 0.543, respectively, and a 51% increase in computer processing time. Using different VEGFR-2 X-ray structures a similar trend was observed with Glu885 flexible conformation presenting the best scores. This study demonstrates that careful use of selective side-chain residue flexibility can improve AutoDock Vina docking score accuracy, without a significant increase in computer processing time. This methodology proved to be a valuable tool in drug design when using VEGFR-2 but will also probably be useful if applied to other protein targets.
Introduction
Angiogenesis is the process of new blood vessel formation from pre-existing vascular networks by capillary sprouting (1) and plays an important role in the pathogenesis of several disorders including cancer, proliferative retinopathies and rheumatoid arthritis (2) . A key regulatory pathway of angiogenesis is mediated by the vascular endothelial growth factor (VEGF) and its cell membrane tyrosine kinase receptor VEGFR-2 (also know as KDR kinase) (3) . Several VEGFR-2 inhibitors have emerged as promising anti-angiogenic agents for possible treatment against a wide variety of cancers. Sorafenib (Bay 43-9006), sunitinib (SU-11248) and pazopanib (GW786034) are VEGFR-2 inhibitors that have been approved for the treatment of advanced renal cell carcinoma (4).
Molecular docking (henceforth referred as docking) and virtual screening are structure-based drug design (SBDD) methods routinely used in modern drug discovery (5) . The existence of VEGFR-2 kinase domain crystal structures enabled the use of SBDD tools to investigate new potential inhibitors. Several studies have been published with modeling studies using VEGFR-2 structures, mostly developing pharmacophore based 3D-QSAR models in order to predict the activity of new synthesized compounds (6) (7) (8) (9) . However the use of docking has been limited to pose inspection of known inhibitors and not to predict VEGFR-2 inhibition activity of small compounds. This is probably because, despite its potential for a wide range of applications, docking continues to face methodological issues and is still not considered accurate enough for virtual screening, as recently reported by Plewczynski et al. (10) . Probably the most notable difficulty of current docking applications is the use of rigid receptor conformations. Receptor flexibility is still a difficult problem due to the computational challenges posed by the numerous degrees of freedom involved in incorporating protein flexibility when performing docking (11) . In fact, it has been shown that, when only a rigid receptor conformation is considered, state-of-the-art docking algorithms predict incorrect binding pose for about 50-70% of all ligands (12) . Several docking programs are currently available including DOCK, FlexX, GOLD, AutoDock4 and AutoDock Vina, just to name the more widely used (10) . Most of these programs can model full ligand flexibility but only a few take receptor flexibility into account and even then only to a limited extent (13) .
In the present work AutoDock Vina (henceforth referred to as ADVina), a freely available program for academic and commercial applications, was used. ADVina provides some degree of protein flexibility by allowing predefined residue side-chains to be flexible during docking (14) . An analysis of VEGFR-2 selective residue side-chain flexibility was performed using this program. A dataset of 123 compounds with known VEGFR-2 inhibition activity was used and the Glu885 flexible conformation provided the best results with a significant docking score accuracy improvement over the rigid conformation. A demonstration that Glu885 flexibility improves scoring accuracy is also provided, even when using different VEGFR-2 X-ray structures. This work proves that a careful selection of residue side-chain flexibility may improve robustness of ADVina docking scores, without an unmanageable increase in computer processing time.
Methods and Materials

Dataset of VEGFR-2 inhibitors
A dataset of 123 compounds, covering four log units (pIC 50 
Preparation of VEGFR-2 flexible conformations
All VEGFR-2 X-ray crystal structures used were extracted from the Protein Data Bank (PDB): 1YWN, 3BE2, 3EWH and 2P2H. Flexible conformations of VEGFR-2 were prepared using the respective crystal structure. The software AutoDockTools was used to extract the co-crystallized ligands from the PDB files, assign polar hydrogens, add gasteiger charges, select the flexible residues side-chains and save the structures in PDBQT file format required to use ADVina. (Table 1 ). All the figures with structure representations were produced using the PyMOL software (2Results and Discussion
Docking with ADVina
Selection of VEGFR-2 flexible residues
A statistical analysis of the PDB databank revealed that 85% of proteins contain one to three flexible residues in the active site (26) , and the inability to consider this flexibility is probably related to the limitations of the flexible ligand-rigid receptor approach. ADVina docking tool provides the possibility to select specific residues as flexible, allowing rotation around torsional degrees of freedom (27) . In this work, we set out to analyze if the flexibility options on ADVina can improve docking accuracy using VEGFR-2 as protein target. VEGFR-2 can be considered as a good candidate for this type of flexibility study as VEGFR-2 structure presents a relatively rigid conformation when comparing the available X-ray structures. Furthermore, VEGFR-2 does not engage in any major conformational alterations when binding to different known inhibitors (Figure 1) .
By comparing the kinase binding pocket of different VEGFR-2 crystal structures, we started by selecting residues with some degree of cross-structure flexibility ( Figure 1 ). The main issue to be aware of at this stage is an increase in degrees of freedom, resulting in more computational time need to perform the docking runs (table 1). From our experience using ADVina, flexibilizing many residue sidechains can result in unpredictable results as it tends to introduce a bias towards lower energies of binding, with a consequent increase in false positives. Also, more flexible residue side-chains results in an increase in the computational processing time need to perform the docking runs. Taken these factors into account, a maximum of 4 flexible residue side-chains was established. After inspecting the kinase active site of several VEGFR-2 structures, 4 residues were selected: Lys868, Glu885, Cys919 and Asp1046.
As can be seen by the superimposition of 4 VEGFR-2 crystal structures, the selected residues present some degree of flexibility (Figure 1 ). Also these residues interact consistently, by forming hydrogen bonds (H-bonds) with the inhibitors that are cocrystallized in the inspected VEGFR-2 structures.
After an extensive survey of the available PDB structures, the VEGFR-2 crystal structure PDB:1YWN was selected (28) . This structure was chosen as it presents low resolution (1.72 A) and has been consistently used in several SBDD studies (6, 7) .
Furthermore, the co-crystallized inhibitor 4-amino-furo [2,3-d] pyrimidine interacts with all the selected residues (Figure 1) . (Table 1 ).
Evaluation of ADVina scoring using VEGFR-2 rigid and flexible conformations
The docking score enrichment was evaluated using several parameters: pearson correlation, spearman rank correlation and docking computational processing time.
Especially in virtual screening, the spearman rank correlation is an important statistical parameter as the position of the compounds within an ordered list is usually more valuable information than the actual docking scores. As more flexible residues are selected, the time need to perform the docking runs should be taken in consideration as there is an increase in the number of rotatable bonds and consequent increase in computational processing time ( Table 1) .
The pearson and spearman rank coefficients obtained using the rigid conformation were 0.223 and 0.456, respectively. These values are in agreement with a recent study using different proteins and docking softwares (10), were eHits software (averaging the results for all the proteins used in the study) was the top performer, with pearson and spearman rank coefficients of 0.380 and 0.470, respectively. When using single flexible residue side-chain conformations, the Glu885 flexible conformation presented the best scores with a sharp pearson coefficient increase (0.568) and a significant spearman rank coefficient increase (0.543). As expected, due to an increase in three rotatable bonds, the Glu885 flexible conformation resulted in a 51 % increase in processing time (table 1) Although this work has been performed using VEGFR-2, we believe that this flexible docking methodology can be applied using other protein targets to improve docking poses and docking scores. To investigate if flexible Glu885 docking scores improvement was independent of the crystal structure used, the same methodology was applied to 3 different VEGFR-2 crystal structures available: 2P2H, 3BE2 and 3EWH ( Table 2 ). The structures were selected according to: structure resolution (lower than 2 Å) and presence of different inhibitors. In all crystal structures used, a consistent improvement in pearson and spearman rank correlations was observed when using the Glu885 flexible conformation compared to the rigid conformation ( Table 2 ). On the other hand, no consistent trend was observed with Glu885-Cys919 and Glu885-Lys868 flexible conformations. In fact all structures presented lower pearson and spearman rank correlation, with the notable exception of Glu885-Lys868 flexible conformations when using the 3BE2 structure.
This study demonstrates that the Glu885 flexible conformation provides the best overall docking scores, using less computer processing time and in a crystal structure independent manner. between the compounds and the amino group of the rigid Lys868 side-chain (Fig. 2a) ,
or an H-bond between the compounds and the carboxyl group of the flexible Glu885 (Fig. 2b ).
Conclusions and future work
In this work, a docking study of selective residue side-chain flexibility was performed using the tyrosine kinase receptor VEGFR-2 as protein target, and ADVina as docking software. It was demonstrated that an important docking score improvement can be obtained with careful binding site analysis and selection of relevant residues. The Glu885 flexible conformation provided the best docking scores and this improvement was observed across all the X-ray structures used. This methodology may be a valuable tool in drug design when performing virtual screening, either using VEGFR-2 or applied to other therapeutic protein targets. To our knowledge it is the first time that an in-depth receptor-flexibility docking study software was performed using ADVina. Figure 1 . Superimposition of the VEGFR-2 selected residues from 4 crystal structures:
Figures
1YWN (sticks and balls representation), 3BE2, 3EWH, 2P2H (line representation).
Light grey the cartoon representation of 1YWN, line green the 1YWN co-crystallized ligand.
